Boston Scientific Streamlines Twin Cities Presence: Minnetonka Site For Sale,Maple Grove Expands
Maple Grove, Minnesota – Boston Scientific, a major medical device manufacturer, is strategically consolidating its operations in the Twin Cities area. This move involves selling its extensive complex in Minnetonka and significantly expanding its facility in Maple Grove.
Real Estate Shift: Minnetonka Out, Maple Grove In
The company recently put its 226,000-square-foot property on 24 acres in Minnetonka on the market, signaling a gradual exit from the western suburb after decades of operation. Simultaneously, just a short drive away in Maple Grove, construction is underway to add 52,000 square feet to the existing 79-acre Weaver Lake campus, located at 1 Scimed Place.
A Boston Scientific spokesperson stated, “Across Boston Scientific, we continuously align our real estate and workspace to support our business strategy as well as our growth. As part of that ongoing process, we made the decision to move employees from our Minnetonka site in Minnesota to our Weaver Lake site in Maple Grove, Minnesota later this year.”
Minnetonka Property Details
The Minnetonka property, now listed by CBRE, features a mix of lab, warehouse, and top-tier office spaces. While the listing doesn’t specify an asking price, Hennepin County property records assess the combined market value of the four adjacent parcels at the 10700 Bren Road W. address at $14.8 million for 2025.
Pro Tip: When considering commercial real estate investments,always analyze property records for assessed market values to gauge fair pricing.
Minnesota’s Vital Role in Boston Scientific
As of March, Boston Scientific employed approximately 10,000 individuals in Minnesota, spread across facilities in Minnetonka, Maple Grove, and a 92-acre complex in Arden Hills. Over the past 15 years, the company’s workforce in the state has roughly doubled. Despite its Massachusetts headquarters, all eight of Boston Scientific’s divisions operate in Minnesota, with its important cardiology segment headquartered within the state.
Specific details regarding the Minnetonka sale remain undisclosed, including the specific business units operating there and potential impacts on employment. However,the listing indicates that boston Scientific is open to leasing the facility until June 2026 but will fully cease operations and vacate the premises by that time.
Property records show that half of the Minnetonka buildings were constructed in 1991, with the remaining structures added in 2007. The property underwent a redevelopment in 2013, according to the listing.
Twin Cities Real Estate Market
The Twin Cities commercial real estate market has seen increased activity as companies reassess their spatial needs post-pandemic. According to a recent report by Cushman & Wakefield, suburban office spaces are being repurposed to accommodate a mix of uses, including lab and research facilities, reflecting the growing demand from the life sciences sector.
Did you Know? the life sciences sector in minnesota has grown by 15% in the last five years, driving demand for specialized real estate.
Boston Scientific’s Minnesota Footprint: At a Glance
| Location | Status | Details |
|---|---|---|
| Minnetonka | For Sale | 226,000 sq. ft complex on 24 acres; mix of lab, warehouse & office. |
| Maple Grove (Weaver Lake) | Expanding | 52,000 sq. ft expansion on existing 79-acre campus. |
| Arden Hills | Operational | 92-acre complex; continues to operate. |
Strategic implications
This consolidation reflects a broader trend among medical device companies to optimize their operational footprints and invest in strategic locations. The expansion in Maple grove suggests a long-term commitment to this location, perhaps centralizing key functions and fostering innovation.
What impact do you think this consolidation will have on the local job market? How might other companies respond to Boston Scientific’s strategic move?
Understanding Medical Device industry Trends
The medical device industry is undergoing significant change, driven by technological advancements, regulatory changes, and evolving healthcare needs. Companies are increasingly focusing on:
- Digital health solutions: Integrating software and data analytics into medical devices to improve patient outcomes.
- Minimally invasive procedures: Developing devices that enable less invasive surgeries, reducing recovery times and costs.
- Personalized medicine: Tailoring treatments to individual patient needs through advanced diagnostics and targeted therapies.
Thes trends are shaping the future of the industry and influencing companies’ investment decisions in research, growth, and infrastructure.
Frequently Asked Questions About Boston Scientific’s Twin cities Consolidation
- Why is Boston Scientific consolidating its operations in the Twin Cities?
- Boston Scientific is aligning its real estate and workspace to better support its business strategy and growth initiatives.
- What will happen to the Boston Scientific Minnetonka location?
- The Boston Scientific complex in Minnetonka is being listed for sale, marking a planned exit from that suburb after several decades of operation.
- Where is Boston Scientific expanding its operations?
- Boston Scientific is expanding its weaver Lake site, located at 1 Scimed Place in Maple Grove, with a 52,000-square-foot addition.
- how many employees does Boston Scientific have in Minnesota?
- As of March,boston Scientific employed approximately 10,000 workers across its Minnesota locations,including Minnetonka,Maple Grove,and Arden Hills.
- when will Boston Scientific completely cease operations at the Minnetonka facility?
- Boston Scientific intends to cease all operations and occupancy at the Minnetonka facility by June 2026.
- What type of facilities are included in the Minnetonka boston Scientific property for sale?
- The Minnetonka parcel includes lab space, warehouse facilities, and high-class office space, making it a versatile property for potential buyers.
What are your thoughts on Boston Scientific’s strategic shift? Share your comments below!